Europe — EMA

Paklitaksel Accord (Paclitaxel)

Paclitaxel, the active ingredient in Paklitaksel Accord, is a taxane presented as a unknown/unknown for intravenous use. It treats various solid tumours in adult oncology patients.

Paclitaxel

Request sourcing

Pack/s

What is Paclitaxel?

Paclitaxel, the active ingredient in Paklitaksel Accord, is a taxane presented as a unknown/unknown for intravenous use. It treats various solid tumours in adult oncology patients. GNH USA supplies Paklitaksel Accord as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, oncology centres, pharmacies and clinics worldwide.

GNH USA supplies Paklitaksel Accord as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals ...

What is Paclitaxel used for?

Paklitaksel Accord uses the taxane class to focus on the cell growth pathways of solid tumours and the following applications: - Cancer of the breast : Provides the primary or ad . - ... ... ...

What are the side effects of Paclitaxel?

Common ...

Information provided on this page is for educational use by procurement and clinical professionals. Always consult a licensed healthcare provider for medical advice and prescribing decisions. GNH USA supplies this product subject to applicable regulatory and licensing requirements.

Send a sourcing enquiry for this product →